How it works?
Senza categoria

HistopathologicaI H&E-Based evaluation of HER2 status in breast cancer through a novel machine learning approach

Carmelo Lupo1*, Nadia Casatta1, Gianluca Gerard2, Gaia Cervi2, Antonio Polonia3, Nicola Fusco4,5, Giuseppe Curigliano4,5, Catarina Eloy3

Poster ECP 35th European Congress of Pathology


Recent evidences introduced a new ‘HER2-low’ expression in breast cancer (BC) clinical practice1. The accurate definition of the HER2 profile is thus showing the need for more sensitive diagnostic tools to ensure that eligible patients are not deprived of effective therapies.


Diapath Lab Talks | Privacy Policy